Statistics for Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Total visits

views
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial 33

Total visits per month

views
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0
May 2025 0
June 2025 0

File Visits

views
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD); a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.pdf 16

Top country views

views
United States 19
Chile 2

Top city views

views
Miami 19
Santiago 2